Open AccessAbnormal liver biochemistry constitutes an independent prognostic factor of a less favorable clinical course in patients with COVID-19
Author(s) -
Carlos Alventosa Mateu,
Juan José Urquijo Ponce,
Francesc Puchades Gimeno,
Salvador Benlloch,
Francisco Sanz Herrero,
Mercedes Latorre Sánchez,
Miguel García Deltoro,
Concepción Gimeno Cardona,
María Dolores Ocete Mochón,
Moisés Diago Madrid
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.7842/2021
Subject(s) - medicine , bilirubin , logistic regression , gastroenterology , retrospective cohort study , covid-19 , clinical significance , correlation , disease , geometry , mathematics , infectious disease (medical specialty)
abnormal liver biochemistry (ALB) is correlated with increased clinical involvement or severity in COVID-19, but its prognostic implications have not been studied extensively. The aim of this study was to determine whether ALB is a risk factor for unfavorable clinical outcome and involvement.